Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor necrosis factor
(
TNF
) increases serum triglycerides in rats by increasing de novo hepatic fatty acid synthesis and very low density lipoprotein production. We have recently shown that several other cytokines increase hepatic fatty acid synthesis in the mouse. We now explore the mechanism by which these cytokines increase de novo lipogenesis and the interactions between cytokines in fed mice.
TNF
administration results in increased hepatic levels of citrate, the primary allosteric activator of
acetyl-CoA carboxylase
, which is the major rate-limiting enzyme for fatty acid synthesis. The
TNF
-induced increase in citrate occurs within 15 min of administration, early enough to account for the acute rise in hepatic fatty acid synthesis seen by 30 min after
TNF
administration. IL-1, which also increases hepatic fatty acid synthesis, produces similar increases in hepatic citrate levels. In contrast, another potent stimulator of hepatic fatty acid synthesis, interferon-alpha (IFN alpha), has no effect on hepatic citrate levels. There were no acute effects of
TNF
or IL-1 on the activation state of
acetyl-CoA carboxylase
. A trend toward an increase in the activation state of
acetyl-CoA carboxylase
was seen after IFN alpha administration. Low doses of
TNF
and IL-1 given in combination show no synergy while maximal doses are not additive. In contrast, when a low dose of either
TNF
or IL-1 is combined with a low dose of IFN alpha, there is synergy in stimulating hepatic fatty acid synthesis. A maximal dose of
TNF
or IL-1 and a high dose of IFN alpha produce a further increase in hepatic fatty acid synthesis. These data support the concept that there are two classes of cytokines that stimulate hepatic fatty acid synthesis, those that can increase hepatic citrate levels and those that cannot.
...
PMID:Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. 197 22
Acetyl coenzyme A (acetyl-CoA) carboxylase activity, amount, and mRNA levels increase during the differentiation of 30A-5 preadipocytes to adipocytes.
Tumor necrosis factor
(
TNF
) completely prevents this differentiation, with concomitant inhibition of
acetyl-CoA carboxylase
mRNA accumulation. To investigate the mechanisms by which
TNF
prevents
acetyl-CoA carboxylase
mRNA accumulation, we determined the effect of
TNF
on the transcription rate of the carboxylase gene and the half-life of carboxylase mRNA. Nuclear runoff transcription assays revealed no differences in the number of RNA polymerase molecules actively engaged in transcription of the
acetyl-CoA carboxylase
gene in preadipocytes, adipocytes,
TNF
-treated preadipocytes, or at any time during the course of differentiation. However, changes in adipsin, glycerophosphate dehydrogenase, and actin mRNAs, whose levels are also differentiation dependent, can be accounted for in part by changes in the number of polymerase complexes on their respective genes. To determine whether
TNF
caused a decrease in the stability of carboxylase RNA transcripts, we measured the rate of decay of prelabeled
acetyl-CoA carboxylase
mRNA. Control and
TNF
-treated cells showed no difference between the apparent half-lives of
acetyl-CoA carboxylase
mRNAs (9 h). However, the rate of
acetyl-CoA carboxylase
mRNA synthesis in vivo was decreased three- to fourfold in the presence of
TNF
. These data demonstrate that
TNF
prevents accumulation of
acetyl-CoA carboxylase
mRNA during preadipocyte differentiation by decreasing the rate of
acetyl-CoA carboxylase
gene transcription. However, transcriptional control is not due to a change in the number of RNA polymerase complexes actively engaged in carboxylase transcript elongation which could be measured by a number runoff assay. Instead, transcriptional control may be related to the rate at which RNA polymerase traverses the
acetyl-CoA carboxylase
gene.
...
PMID:Transcriptional regulation of acetyl coenzyme A carboxylase gene expression by tumor necrosis factor in 30A-5 preadipocytes. 256 9
Tumor necrosis factor
(
TNF
) is secreted by macrophages in response to various stimuli and blocks lipid accumulation during the conversion of preadipocytes to adipocytes in culture. In the present report, we investigate the effect of recombinant
TNF
on the expression of acetyl-coenzyme-A (CoA) carboxylase, the rate-limiting enzyme for long-chain fatty acid biosynthesis. We used a preadipocyte cell line, 30A-5, derived from 10T1/2 mouse fibroblasts after treatment with 5-azacytidine. Treatment of the preadipocyte cell line with dexamethasone and insulin triggers the conversion of these cells to mature adipocytes as evidenced by the accumulation of lipid. The mRNA and enzyme levels of
acetyl-CoA carboxylase
as well as the enzyme activity increase markedly during the conversion process.
TNF
prevents the conversion of preadipocytes to adipocytes with a concomitant inhibition in the accumulation of
acetyl-CoA carboxylase
mRNA and decrease in enzyme activity. This observed reduction in
acetyl-CoA carboxylase
mRNA levels is reversible upon removal of
TNF
.
Acetyl-CoA carboxylase
mRNA levels and enzyme activity also decrease when fully differentiated adipocytes are exposed to
TNF
but to a much lesser extent. These results suggest that
TNF
affects de novo lipid synthesis in part by altering the mRNA levels of
acetyl-CoA carboxylase
.
...
PMID:Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and preadipocyte differentiation. 290 66